| 标题 |
Efficacy and safety of zalfermin co-administered with semaglutide in participants with fibrosis and cirrhosis due to metabolic dysfunction-associated steatohepatitis: a phase 2, dose-ranging, double-blind, randomised controlled trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Gastroenterology and Hepatology 作者:R. Loomba; Jacob George; Laurent Castera; Sven M. Francque; Eric J Lawitz; et al 出版日期:2026-07-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)